Results 151 to 160 of about 1,087,727 (251)
ABSTRACT Objective Breast cancer (BC) is a disease with a subtle onset, often diagnosed late, and has a high mortality rate. This study aimed to identify long non‐coding RNAs (lncRNAs) linked to BC as prognostic markers using bioinformatics and initial experiments, explore their regulatory pathways, and assess their expression and prognostic ...
Yuhan Zheng +5 more
wiley +1 more source
Integrative genetic, single‐cell, and perturbation analyses identify CSF1R as a macrophage‐centered immunometabolic signaling hub linking iron dysregulation to osteoarthritis. CSF1R‐driven monocyte–macrophage remodeling may coordinate immune activation, extracellular matrix remodeling, and cartilage degeneration, providing a potential therapeutic ...
Yue Zhou +6 more
wiley +1 more source
Exploratory economic evaluation of allogeneic NK‐cell therapy for paediatric solid tumors, highlighting treatment costs and the clinical benefit required for cost‐effectiveness. Figure made in ©BioRender—biorender.com. Abstract Objectives Natural killer (NK) cell therapy is a promising allogeneic, off‐the‐shelf immunotherapy for solid tumors, yet ...
Sabera Tabassum Wahid +6 more
wiley +1 more source
Cutting Edge: Roles for Batf3-Dependent APCs in the Rejection of Minor Histocompatibility Antigen-Mismatched Grafts. [PDF]
Atif SM +10 more
europepmc +1 more source
In infants with necrotising enterocolitis (NEC), excessive inflammation and epithelial cell death promote the epithelial–mesenchymal transition (EMT), leading to damage to intestinal barriers and the translocation of bacteria and toxins. In addition, inflamed epithelia release cytokines to strengthen the inflammatory response.
Xiao‐Chen Liu +12 more
wiley +1 more source
Development of a Minor Histocompatibility Antigen Vaccine Regimen in the Canine Model of Hematopoietic Cell Transplantation. [PDF]
Rosinski SL +8 more
europepmc +1 more source
Spatiotemporal immune heterogeneity and precision immunotherapy for ovarian cancer
Graphical Highlights Spatiotemporal immune heterogeneity shapes distinct and evolving immune ecosystems in ovarian cancer. Multimodal biomarkers enable biologically informed patient stratification beyond static single‐marker approaches. Precision immunotherapy should match dominant immune barriers across lesions and treatment stages.
Xinfeng Yang +9 more
wiley +1 more source
Integrated whole genome and transcriptome analysis identified a therapeutic minor histocompatibility antigen encoded by an alternative ITGB2 transcript [PDF]
Pont M +12 more
europepmc +1 more source
ABSTRACT Latent autoimmune diabetes in adults (LADA) is a heterogeneous form of autoimmune diabetes characterised by adult onset, the presence of islet autoantibodies, and a slower progression to insulin dependence compared with classical type 1 diabetes.
Moncef Zouali
wiley +1 more source
Selection and Characterisation of Minor Histocompatibility Antigen-Specific Regulatory T Cells in Fully HLA-Matched Setting for GVHD Therapy. [PDF]
Pacini CP +5 more
europepmc +1 more source

